Peptide Distributor Agreements: Minimums, Exclusivity and Territory Terms

TL;DR

A peptide distributor agreement is the contract that decides how much you must buy, where only you can sell, and how either side can walk away. Get those terms wrong and you can be stuck with inventory you cannot sell, or lose a region you built.

One default to know before you sign: under UCC 2-306, an exclusive deal obligates both sides to best efforts unless the contract says otherwise: the seller to supply, the buyer to promote sales.

This guide covers the terms to negotiate: minimum order commitments, exclusivity, territory, termination notice, quality documents per lot, and who controls the labeling.

Key Facts

Each section below gives the clause, what to ask for, and the weak version to push back on.

The agreement should also state who writes product pages and support replies so the brand stays on research use only facts. Always have a business attorney review the final contract.

Minimum Order Commitments

A minimum order commitment is a promise to buy a set amount of product over a period, such as a quarter or a year. A founder should ask the supplier for a schedule that starts low and steps up only as sales grow. A bad version of this clause sets a high fixed volume with no adjustment if demand is slow. If the deal sets quantity by output or requirements instead of a fixed minimum, the Uniform Commercial Code says such a quantity means the actual output or requirements that occur in good faith, and neither side may demand a quantity unreasonably out of proportion to a stated estimate (Cornell Legal Information Institute: UCC 2-306).

Exclusivity and Territory

An exclusivity clause gives a distributor the sole right to sell a supplier's catalog in a defined region. The territory should be described with clear borders, such as a country or a list of states. A founder needs to ask what happens if the supplier sells direct to a lab in that same territory. Under the Uniform Commercial Code, an exclusive dealing agreement imposes, unless otherwise agreed, an obligation by the seller to use best efforts to supply the goods and by the buyer to use best efforts to promote their sale (Cornell Legal Information Institute: UCC 2-306). A bad version of this clause grants exclusivity but lets the supplier keep house accounts or sell on marketplaces that ship into the territory.

Termination Notice

A termination clause states how many days of written notice one party must give the other to end the agreement. A founder should ask for a notice period long enough to sell remaining inventory and notify lab customers. A bad version allows termination with very short notice, leaving a distributor with unsellable stock. The Uniform Commercial Code states that ending a contract, except on an agreed event, requires reasonable notification (Cornell Legal Information Institute: UCC 2-309).

Quality Documents Per Lot

A quality documents clause requires the supplier to send a certificate of analysis and a mass spec report for each production lot. A founder should ask that these documents are delivered before or with the shipment. A bad version of this clause promises documents but sets no deadline or lets the supplier deliver them weeks later. Receiving a batch without paperwork creates a business risk because the distributor cannot confirm what is in the vial before listing it for sale.

Labeling Responsibility

The agreement must state who writes the product label, the product page copy, and the customer support scripts. The FDA judges intended use by the objective intent of the people legally responsible for labeling (Cornell Legal Information Institute: 21 CFR 201.128). The same section adds that a distributor who intends other uses than its supplier must supply labeling for them. A founder should ask for a clause that gives the distributor final approval over all public facing words. The FDA posts warning letters on a public list (FDA: Warning Letters). A bad version of this clause is silent on labeling, leaving the distributor responsible for words they did not write.

Keep product pages and support replies on research use only facts. Watch buyer order patterns, such as a new account placing a very large first order with no prior inquiry about purity or solubility. A founder should train support staff to answer only with molecular weight, sequence, and storage conditions.

This article explains common contract terms. It is not legal advice. A founder should have a business attorney review the final distributor agreement before signing.

To discuss building a research use only peptide brand, Book Your Call.

Payment Terms and Currency Risk

Payment terms decide when money moves relative to shipment. One option is to pay half with the order and half before the carrier issues the air waybill or other shipping document. Ask whether the maker wants full payment to start a custom synthesis run. Ask for a clear payment schedule in the body of the deal. A schedule ties each payment to a real event you can track. That way you do not pay for a step the lab has not yet finished. It also keeps your cash flow steady and safe.

Currency moves between the order date and the settlement date can change your landed cost. If the maker prices in their local money, you carry the exchange risk from order date to settlement date. You can ask for pricing in your home currency to lock the cost. If the maker will not budge, add a price floor and ceiling to the deal. A band sets a worst case rate you both can live with. This stops a sudden currency swing from wiping out your margin on a large order.

Escrow for First Runs

A third party escrow service holds your funds until the maker ships the goods. The maker sees the money is real and starts the batch. Set the escrow terms so the money moves only when the shipping document reaches the escrow portal. Consider escrow for a first order with a new lab. It builds trust when no track record exists between the two firms.

Ask the escrow service what it charges to hold the funds. Agree in writing who pays that fee before you open the escrow. Set a clear release rule tied to a shipping scan, not just a label print. A scan shows the carrier has logged the box, which a label print alone does not.

Late Payment and Cure Periods

A late payment clause gives the maker the right to pause work if funds do not arrive on time. The deal should grant a cure period, stated in business days. During that window you can fix a bank delay without losing your production slot. After the cure period ends, the maker can stop the batch and keep the deposit. That loss of slot and cash hurts, so treat the cure window as a hard deadline.

If the maker wants a late fee on the overdue sum, have your attorney check that the rate is allowed where you operate. A better path is to tie the fee to a published base rate plus a small spread. That keeps the fee fair and easy to defend if a dispute ever lands in court.

Specification Sheets and Batch Records

A spec sheet sets the pass or fail line for every lot you buy. It lists purity, mass, solubility, and storage heat range. The deal must name the test method used for each line, such as HPLC or LCMS. Without a method, a number on a page means little. Attach the spec sheet as an exhibit to the main deal, and state that a lot short of a listed spec entitles you to a fix or a refund.

Batch records show the step by step story of how your lot was made and checked. Ask for a summary record with each shipment, not just a final purity number. A good record lists raw lot codes, column types, buffer pH, and the tech who signed off. These facts help you spot drift across lots before it becomes a big problem. They also give your own QA team a solid trail to audit if a customer raises a question about a vial.

Defining a Rejection Threshold

A rejection threshold is the exact number that lets you say no to a lot. For a peptide, one gate to set is purity by HPLC. Set the floor at a number your lab can meet and your buyers need, and write it into the spec. Write the threshold as a number with one decimal place to avoid rounding fights. For example, if your floor is ninety five and the cert shows ninety four point nine, the lot fails.

The deal must state how a failed lot is handled. The maker can offer a re run at their cost or a full refund of the lot price. Set a time limit for the re run, such as twenty business days. If the re run also fails, you can cancel that line and buy elsewhere. A clear rejection path keeps a bad lot from stalling your supply chain for weeks while you wait for a fix that never comes.

Retain Samples and Third Party Testing

A retain sample is a small sealed aliquot the maker keeps from your lot. The deal should require the lab to hold it for at least one year after the ship date. If a purity dispute pops up later, you can ask for that retain to be sent to a neutral third party lab. You and the maker split the cost of the third party test. Its result is final and binding on both sides.

Pick the third party lab before you sign the deal and name it in the text. Look for an accredited lab with peptide experience. Agree on the test method it will use so the playing field is level. This step turns a messy he said, she said fight into a clean, fast ruling. It saves the business bond by removing blame and focusing on data.

Shipping, Insurance and Loss in Transit

Agree on cold chain control from the lab door to your dock. The deal must state the allowed heat range during transit. It must also name who pays for the data logger that rides inside the box. A logger records the temperature at set intervals through the trip. If the logger shows a spike above the agreed range, you have grounds to reject the lot even if it looks fine.

Each Incoterms rule specifies when the risk of loss or damage to the goods passes from the seller to the buyer (trade.gov: Know Your Incoterms). Name the rule in the deal, ask your freight broker where it puts the risk for an air shipment, and pick the rule that matches your insurance cover.

Insurance Coverage and Claims

Read the carrier's liability limit and check whether it would replace a lost peptide box. Ask the maker to buy all risk cargo insurance for the full invoice value of each shipment. Ask for the premium in writing so you can weigh it against the invoice value. The deal should name you as the loss payee on the policy. That way the insurer pays you directly if a box goes missing or arrives thawed.

Note the carrier's claim window and file within it. Open every box on camera and record the logger data right away. Send the maker a written notice of loss with photos and the logger file attached. File fast and document well, so the carrier has less room to argue that the damage happened after you signed for the box.

Dry Ice and Customs Delays

Plan for a possible customs hold and for how long the dry ice will last. The deal should state how much dry ice the maker packs and how long it is expected to hold. If customs takes longer, the ice runs out and the product warms up. Agree who eats that loss when a hold exceeds the packed time. Ask whether the maker will share that risk for large orders.

You can lower this risk by giving the maker a full set of customs papers before the ship date. Ask the maker to supply a correct harmonized code, a clear description, and a research use only letter with each box. You can also ask the maker to split a big order into two smaller boxes on different days. That way one hold does not trap your whole stock. Weigh the extra freight cost against the cost of losing a full batch.

Intellectual Property and Process Ownership

When you pay for a custom peptide synthesis, you need to own the process that makes it. The deal must state that any method, step, or condition the lab creates for your sequence belongs to you. This stops the lab from using your paid work to serve a rival buyer. Ask your attorney for an assignment clause in the main body of the deal that transfers that process to you. Without clear terms, ownership of the process can be disputed.

You also need a promise that the sequence itself does not step on a known patent. Ask the maker to warrant that, to their knowledge, the peptide you ordered does not infringe a third party claim. This is not a full legal shield, but it shows you acted in good faith. If a patent holder sends you a letter later, you can point back to the maker's promise. That helps you ask the maker to join the defense or cover part of the cost.

Sequence Confidentiality

A confidentiality clause keeps your peptide sequence out of the lab's sales catalog. The clause must bar the maker from listing your sequence, mass, or any data that would let a rival guess the structure. It must also bar the lab from using your sequence in a grant paper or a poster without your written okay. A leak in a public abstract can expose your research edge.

Set a time limit on the duty, counted from the last shipment. After that, the lab can use the general method know how but still cannot share your exact sequence. If the lab breaks the clause, the deal should give you the right to get a court order to stop the leak fast. Money paid after the fact will not put a leaked secret back.

Background IP and Tool Compounds

The lab brings its own tools to the job: resin types, linker chemistry, and cleavage mixes. The deal must say that these background tools stay owned by the lab. You get a paid up right to use the resulting peptide, but you do not own the lab's core chemistry. This line keeps both sides clear on what each party brings to the table and what each takes away when the deal ends.

If the lab uses a tool compound, such as a special amino acid building block it invented, you need a broad use right. The deal should let you use that building block in any peptide you order from that lab. You do not want to renegotiate a license for each new sequence. A single clause that covers all future orders saves time and legal fees down the road.

Audit Rights and Site Visits

An audit clause lets you check the lab's books and benches with your own eyes. For a financial audit, you can ask to see records that tie your payments to the raw materials bought for your batch. This keeps a lab from charging you for a full kilo of resin when your run used only half. A financial audit right can be limited to once per year and must happen during normal business hours. You pay your own auditor, unless the audit finds a shortfall over five percent.

A technical audit lets your QA person walk the lab floor and watch a run. You can check that the HPLC column is the model listed in the batch record. You can see if the cold storage unit logs match the ship data. A technical audit lets you see what a paper cert only describes. It also tells the lab that you are a serious buyer who pays attention to detail. Agree in writing how often a technical visit may happen and how much notice the lab gets.

Scope and Notice for Audits

Write the audit scope into the deal so the lab knows what you will check. A scope list might include the weighing log, the HPLC raw data file, and the cold room temp chart. Do not ask for things outside the scope, like a peek at another buyer's batch record. A tight scope protects the lab's other clients and keeps your audit fast and focused. Plan the visit length around the key points you need to check.

Give the lab at least four weeks written notice before you show up. A short notice window can put the lab on edge and make the visit feel like a raid. A long notice window lets the lab schedule staff to walk with you and pull the records you need. If you find a real problem, the deal should let you come back for a follow up visit within sixty days. That second visit makes sure the fix is real and not just a paper promise.

Remote Audit Alternatives

Compare the travel cost of a full site visit with a remote audit, which may cover much of the same ground. The lab can share a live video feed of the balance room and the HPLC stack. They can screen share the raw data file while you watch in real time. A remote audit works well for a mid year check between on site visits.

The deal should state that a remote audit carries the same weight as an in person visit. The lab must agree to point the camera where you ask and not cut the feed. Record the session with the lab's consent and save the file with your batch records. If a dispute arises later, that video is strong proof of what the lab showed you on that day.

Force Majeure and Supply Chain Failures

A force majeure clause can excuse performance when a big outside event hits, depending on its wording and the governing law. Fires, floods, strikes, and new trade bans are examples you can list. The clause should list the events that count and say what happens next. The maker must tell you within five days of the event and give a best guess on how long the stop will last. If the stop runs more than sixty days, you should have the right to cancel open orders without a fee.

Do not let the clause be a blank check. Watch for vague terms like market hardship or raw material shortage. Define a force majeure event in the deal as one the lab cannot plan for or avoid with backup stock. Push back on any wording that lets the lab walk away just because a supply got more costly. Exclude price hikes from the clause. Keep the clause narrow and tied to real, rare events.

Raw Material Backup Plans

A smart deal names the key raw inputs for your peptide, such as a rare amino acid or a special resin. It then asks the maker to keep a safety stock of those inputs on hand. One ask is enough stock to cover your next two forecast orders. That buffer gives the maker time to find a new source if the main supplier fails. It also gives you time to adjust your own sales plan without a sudden stock out.

Ask whether the cost of that safety stock is built into your unit price. Ask the maker to show you a monthly stock report for your key inputs. The report can be a simple list of item codes and days of cover on hand. If the cover drops below the agreed floor, the maker must order more within a set window. This small bit of shared data keeps a supply shock from becoming a business crisis for you.

Allocation Rules in a Shortage

When a raw input runs short, the maker must decide how to split what is left among its buyers. The deal should state that you get a pro rata share based on your last twelve months of orders. This stops the maker from giving all the remaining stock to its biggest client and leaving you with nothing. A fair split keeps your business alive while the market works through the tight spell.

The maker must tell you about an allocation event as soon as it knows a shortfall is coming. You then get a written plan that shows the total stock, your share, and the expected end date of the shortfall. If the maker hides the problem and ships late, you lose trust and sales. A clear, early warning lets you tell your own customers about a delay before they run out of stock on their shelves.

Stability Data and Retest Windows

Ask the maker for stability data showing how long the peptide stays in spec under the agreed storage conditions. The distributor needs to know how long a batch stays within spec after it ships. The manufacturer should share real time stability data for one or more representative batches. That data shows purity and content at set time points under the agreed storage conditions. A retest window is the period during which the product can be tested again and still be sold if it passes. Agree that the window starts on the date of manufacture and runs for a period the agreement names. The agreement should state who pays for the retest work and how the results are shared.

If a batch nears the end of its window while sitting in a distributor warehouse the parties need a clear path. One option is to send a retain sample to a third party lab to retest it against the agreed spec. If the batch passes the window can be extended for a set number of months. The extension must be recorded in a short letter signed by the quality unit of the manufacturer. Without this clause the distributor may be stuck with product its own quality policy does not allow it to ship. The clause protects the value of slow moving inventory.

Setting the Initial Window

The first window is based on data the manufacturer already holds. Ask for a summary that covers at least three batches stored at the long term temperature listed on the label. The summary should show purity by HPLC and net peptide content at zero, six, twelve, and twenty four months. If the product is new and long term data is thin the parties can set a short window of twelve months and extend it as more data come in. The agreement should let the distributor see the updated stability tables each year.

Do not accept a window that starts on the ship date alone. The true clock starts when the batch is made and filled. A batch that sat in a freezer for eight months before shipping has already used part of its life. The agreement must define the start point as the date of final lyophilization or the date of fill. This keeps the distributor from buying time that was already spent.

Extension and Out of Spec Results

A retest extension is not automatic. The manufacturer must test the retain sample and share the full report within a set number of days. If the sample fails any part of the spec the extension is denied and the batch is expired. The distributor should have the right to witness the test or send the retain to its own lab for a split check. The cost of a failed retest should fall on the manufacturer unless the failure is clearly due to how the distributor stored the product.

When a batch fails retest the agreement should say what happens to unsold stock. The manufacturer may offer a credit toward a future run or a refund of the price paid. The distributor should not bear the full loss for a stability failure that happened before the product was sold. A fair clause splits the risk and keeps both sides focused on making and storing the product the right way from day one.

Change Control for Raw Materials

A peptide is only as clean as the amino acids and solvents used to build it. When a manufacturer switches a raw material source the final product can shift in ways that matter to a research customer. The agreement must require advance notice of any change to a critical starting material. A critical material is any input that touches the peptide chain or the final purification step. The notice should come at least sixty days before the change hits a shipped batch. That gives the distributor time to test a sample and talk to key accounts.

The notice should include the name of the new supplier, the grade of the material, and any change in the impurity profile. If the new material brings a different solvent peak or a new trace metal the research data may look odd. The distributor needs to know so it can update its own quality file and tell labs that run long term studies. A silent change can break trust with a lab that sees a shift in its assay. The clause keeps the supply chain clear and honest.

Defining a Major versus Minor Change

Not every change needs a full revalidation. The parties can sort changes into two buckets. A major change is a new source of Fmoc amino acid, a new resin, or a new solvent for the cleavage step. A minor change is a new lot of the same grade from the same supplier or a new desiccant pack. Major changes need the sixty day notice and a sample for the distributor to test. Minor changes can be logged in a quarterly summary report.

The agreement should list what counts as major in a short table. That table removes guesswork and keeps the manufacturer from calling a big shift a small tweak. If the parties cannot agree on a bucket for a new change they should default to the major change path. Weigh the cost of a quick test against the cost of a lost account. A clear table saves time and phone calls.

Testing the Changed Material

The distributor should get a small sample from the first pilot run with the new raw material. That sample can be sent to a third party lab for a side by side check against the prior batch. The check should cover HPLC purity, mass spec identity, and any residual solvent peaks that are new. If the results match within the agreed margin the change is cleared for production. The manufacturer can then ship full batches made with the new input.

If the sample shows a new peak above the reporting threshold the parties must pause and dig into the cause. The manufacturer may need to adjust the purification step or pick a different supplier. The distributor should not be forced to accept a product that looks different on its face. The clause gives both sides a safe way to adapt the supply chain without breaking the spec or the relationship.

Reference Standard Supply

A reference standard is a well characterized sample of the peptide kept to check future batches. Ask the manufacturer how it uses the standard to calibrate the HPLC and confirm the mass spec for each new lot. The distributor may also need a standard to send to a third party lab or to a large account that runs its own quality check. The agreement should say how much standard the manufacturer will supply and at what cost. The standard must come with its own certificate of analysis that lists purity, mass, and storage conditions.

The standard should be from the same synthesis campaign as the first approved batch. If the manufacturer runs out of that campaign it must bridge a new standard to the old one. Bridging means running both side by side and showing they give the same result within a tight margin. The data from the bridge study must be shared with the distributor. Without a shared standard the two sides can get different purity numbers from the same batch and waste time arguing over whose instrument is right.

Storage and Shelf Life of the Standard

A reference standard is a fragile tool. It must be stored cold, dry, and away from light. The manufacturer should aliquot the standard into small sealed vials so one vial can be used per test without thawing the whole stock. The agreement should state the storage temperature and the shelf life of the standard in its unopened vial. The manufacturer must replace the standard at no charge if it degrades before its marked expiry.

The distributor should keep a log of when each vial is opened and how it is handled. If a test result looks off the log helps rule out a bad standard as the cause. The manufacturer has the right to ask for the log before sending a free replacement. This keeps both sides careful with a costly and limited resource. A small amount of care saves a lot of batch testing time.

Cost and Reorder Terms

The first standard should be included in the cost of the initial batch run. If the distributor needs more later the price per vial should be set in the agreement. A fair price covers the cost of making, testing, and shipping the standard plus a small markup. The lead time for a new standard should not exceed thirty days. If the manufacturer cannot supply a standard in that time the distributor may have a qualified lab make one and deduct the cost from the next payment.

The right to make a standard externally is a backstop. It keeps the distributor from being stuck without a key quality tool. The external standard must be bridged to the original and the data shared with the manufacturer. The clause gives you a remedy if the supply of standards fails. Both sides want the same thing: a stable yardstick that makes every batch test the same way.

Subcontractor Disclosure and Oversight

Ask whether the manufacturer uses outside labs for steps like mass spec, amino acid analysis, endotoxin testing, or the final fill and lyophilization. Ask for the right to know who touches the product and where. The agreement should require the manufacturer to list all subcontractors that handle the peptide or the data that supports the certificate of analysis. The list must be updated within ten days of any change. A hidden subcontractor is a risk to quality and to the chain of custody.

The manufacturer must flow down the quality terms of the distributor agreement to each subcontractor. That means the subcontractor agrees to the same audit rights, document retention rules, and confidentiality duties. State that if a subcontractor causes a batch failure the manufacturer stays fully responsible to the distributor. The distributor does not have to chase a third party it did not choose. The clause keeps the lines of responsibility clean and gives the distributor one throat to choke.

Audit Rights at Subcontractor Sites

The distributor should have the right to visit a subcontractor site under the same terms as a visit to the main facility. The manufacturer must arrange the visit and have a staff member present. The scope of the visit can be narrow and focus only on the step the subcontractor performs. A visit to a fill lab might check the lyophilization cycle logs and the sterility of the fill suite. The visit should not be used to fish for other clients' data.

If a subcontractor refuses a visit the manufacturer must find a replacement that will agree. The distributor should not be forced to accept a black box in the supply chain. The cost of the visit is borne by the distributor unless a serious quality gap is found. In that case the manufacturer pays. This gives the distributor a tool to check the parts of the process it cannot see from a paper audit.

Data Integrity at Subcontractor Labs

A subcontractor that runs a purity test must send the raw data file to the manufacturer. The manufacturer must keep that file and share it with the distributor on request. The file should show the full chromatogram, not just the integrated peak table. A cropped or re scaled file can hide a shoulder peak that matters. The agreement should state that the subcontractor cannot delete or alter raw data without a documented reason and a quality unit sign off.

The manufacturer must audit its subcontractors at least once every two years and share a summary of the audit with the distributor. The summary can hide the subcontractor's other clients and pricing but must show the quality findings. If a major gap is found the manufacturer must show the corrective action plan. This keeps the whole chain honest without forcing the distributor to audit every small lab itself.

Forecast Sharing and Capacity Reservation

A distributor that sells to research labs needs the manufacturer to hold space in the production queue. Without a shared forecast the manufacturer may book other work and push the peptide run out by months. The agreement should require the distributor to send a rolling six month forecast every quarter. The forecast is not a binding order but a good faith estimate of need. The manufacturer must reserve capacity for the forecasted amount plus a buffer of twenty percent. The buffer lets the distributor respond to a sudden large order from a lab.

The manufacturer should confirm within two weeks whether it can hold the capacity. If it cannot it must say so early so the distributor can find a second source. The forecast clause works both ways. It gives the manufacturer the confidence to buy raw materials ahead of time. It gives the distributor the confidence to tell a lab that supply will be steady. A shared forecast cuts the risk of stock outs and rush fees.

Binding Portion of the Forecast

The first month of the forecast can be made binding. That means the distributor must buy at least eighty percent of the amount it said it would need. The manufacturer must have that amount ready to ship by the first week of the month. If the manufacturer fails to ship on time it pays for the distributor's air freight on the next order. If the distributor buys less than eighty percent it pays a small fee per vial to cover the idle capacity.

The binding portion should not be a trap. The fee should be low and capped at the cost of the raw materials that were set aside. The goal is to align planning, not to punish. A fair fee might be ten percent of the value of the shortfall. The clause keeps both sides honest about their numbers without making the forecast a weapon.

Capacity Review Meetings

Once a quarter the operations leads from both sides should hold a short call. They review the forecast, the current queue, and any new projects that may need a slot. The call should be informal and last no more than thirty minutes. The manufacturer shares a simple line list of planned runs and open slots. The distributor shares any news about large tenders or grants that may shift demand.

The meeting is not a contract renegotiation. It is a chance to spot a clash before it becomes a crisis. If a big run is coming the manufacturer can order the resin and solvents early and avoid a lead time spike. The agreement should state that the meeting is required but the notes are not binding. A short call every three months saves a lot of urgent emails later.

Dispute Resolution and Escalation Path

Even a well written agreement will hit a point of friction. A batch may arrive with a purity number that is just on the line. A payment may be late due to a bank error. The parties need a clear path to solve the problem before it grows into a legal fight. The agreement should lay out three steps. First, the quality or operations leads talk directly within five business days. Second, if they cannot agree the issue goes to the heads of each company. Third, if the heads cannot solve it the parties go to mediation.

The first step is the most important. A dispute about data or timing may be solved with a shared screen and a phone call. The clause should require the leads to exchange all relevant records before the call. A purity dispute needs the full HPLC file from both sides. A payment dispute needs the wire trace and the invoice. With the facts on the table most issues shrink. The clause forces that table to be set early.

Mediation Rules and Cost

If the leads and the heads cannot agree the parties must try mediation before they can sue or start arbitration. Mediation is a meeting with a neutral third person who helps the parties find a deal. Ask your attorney how its cost and timing compare with court. The agreement should name a mediation provider like JAMS or the CPR Institute. The cost of the mediator is split equally. Each side pays its own lawyer and travel.

The mediation must happen within sixty days of the written request. The location should be a neutral city that is easy for both sides to reach. If the parties reach a deal it is written and signed and becomes part of the agreement. If they do not reach a deal they are free to go to the next step. Write the mediation clause so it does not block a party from seeking a quick court order to stop an urgent harm like a leak of secret data.

Governing Law and Venue

The agreement must say which state or country's law will govern it. For a U.S. distributor buying from a U.S. manufacturer one choice is Delaware or the state where the manufacturer is based. The choice of law should be paired with a clear venue for any court case. The venue should be a specific county, not a vague region. This stops a party from being dragged to a court far from its office.

The clause should also say that the prevailing party in any court case gets its reasonable legal fees paid by the other side. This keeps both parties from filing weak claims just to force a settlement. Make the fee shift clause mutual, and have your attorney check how it reads under your state's law. A fair dispute path keeps the focus on solving the problem, not on winning a fight.

How the Evidence Checklist Works

• Read the approved source before treating a concern or platform statement in this guide as current.
• Record the date you checked the approved source so a later audit can separate old wording from current wording.
• Keep every qualifier from the approved source when you turn a source statement into an operating step.
• Use the approved source to verify only what the page states, then leave any unstated cause or result unknown.
• Recheck the approved source after a platform update before reusing this decision record.
• Separate the observed statement at the approved source from the operator-created framework in this guide.

Frequently Asked Questions

What is a minimum order commitment in a peptide distributor agreement?

It is a promise to buy a set amount of product over a period, such as a quarter or a year. Ask the supplier for a schedule that starts low and steps up only as sales grow.

What does an exclusive territory give a peptide distributor?

It gives the distributor the sole right to sell a supplier's catalog in a defined region. Under UCC 2-306, unless the parties agree otherwise, an exclusive dealing deal binds the seller to use best efforts to supply the goods and the buyer to use best efforts to promote their sale.

How much notice should a distributor agreement require to end it?

The Uniform Commercial Code says that ending a contract, except on an agreed event, requires reasonable notification to the other party. Ask for a notice period long enough to sell remaining inventory and tell your lab customers.

Which documents should come with each peptide lot?

Ask for a certificate of analysis and a mass spec report for each production lot. They should arrive before or with the shipment, so you can confirm what is in the vial before you list it.

Who should control the label and product page copy?

The distributor should have final approval over all public facing words. The FDA judges intended use by the objective intent of the people legally responsible for labeling, under 21 CFR 201.128.

What should a founder do next before signing?

Have a business attorney review the final distributor agreement. This article explains common contract terms and is not legal advice.

If you want help applying this guide to your operation, Book Your Call.

Sources

• Primary source at www.law.cornell.edu: https://www.law.cornell.edu/ucc/2/2-306
• Primary source at www.law.cornell.edu: https://www.law.cornell.edu/ucc/2/2-309
• Primary source at www.law.cornell.edu: https://www.law.cornell.edu/cfr/text/21/201.128
• Primary source at www.fda.gov: https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters
• Primary source at www.trade.gov: https://www.trade.gov/know-your-incoterms